Alan Ganz, Ph.D.  --  is the founder and Principal of  Instrumental Solutions, LLC, a technology consulting firm specializing in the development of analytical instruments.  He works both as a hands-on physicist, conducting his own research in optical  spectroscopy and as a management consultant.  Dr. Ganz feels that his ongoing responsibility in the lab ensures that his management advice remains realistic, up-to-date and sensitive to the evolving capacity of R&D staff. 

He began his industrial career at Exxon Production Research Corporation in Houston, where his spectroscopic studies of surfactant solutions were tied to novel ways of extracting oil.  From the experimental lab bench, Dr. Ganz moved to a desk at a specialized defense-related think tank, Mission Research Corporation, Santa Barbara, CA.  As group leader in the infrared program, Dr. Ganz was responsible for collaborative projects with major aerospace companies as well as with the US government.  This position led to his assuming the Program Manager role for an Air Force Space Optics project at Perkin-Elmer’s government business in Connecticut .

In 1987, Dr. Ganz crossed over to the commercial side of Perkin-Elmer’s business, undertaking a series of broadening assignments.   As a member of the Applied Technology Group, he was able to work on virtually any of the company’s existing or anticipated technologies.  Dr. Ganz was recognized for his contributions and his enthusiasm and promoted to Director of an experimental unit charged with creating devices for noninvasive medical diagnostics.  Reporting to the Chief Technology Officer, Dr. Ganz performed both management functions and scientific investigations. 

After several years of hands-on experience as a practicing engineer in several technical positions, Mr. Aker decided to return to school and become a patent attorney.  He has since practiced intellectual property law with private firms and in corporate legal departments.  Mr. Aker worked as an Intellectual Property Law Attorney with the Research Division of IBM and was Chief Patent Counsel, Analytical Instruments Division, of the company that was formerly The Perkin-Elmer Corporation in Norwalk, CT., a leading manufacturer of analytical instruments and life science systems.  He was also Patent Counsel for KX Industries, L.P. in Orange, CT, the world’s largest manufacturer of carbon block water filters. 

Although there are many patents that Mr. Aker wrote and prosecuted that issued under the names of firms where he worked, the list of IP issued in his name reveals the breadth of his work.  A search on the United States Patent and Trademark Office web site under his name as attorney of record will reveal over 140 patents in a wide range of complex technologies.  

Mr. Aker has taught Patent Law and related courses at the Touro College, Jacob D. Fuchsberg Law Center since 1983.  There he received the school's first annual Adjunct Professor of the Year award in 1998.   

Dr. Cahill is very experienced in both system and optical design.  He has conceived and optimized many optical designs for stability and light throughput.  He is also skilled in using radiometric calculations of signal and noise levels to predict measurement sensitivity.  He has applied these techniques to both absorption and emission systems utilizing conventional as well as fiber optics.  His ability to quickly predict the performance of proposed designs enables him to optimize system designs quickly and cost effectively.

In a complementary fashion, Dr. Cahill also maintains a sharp eye during experimental evaluation, and has contributed to many product improvements.  He is often called upon to trouble shoot quality problems, review designs, and to assess new technologies.   In addition to his purely technical work, he has successfully planned and managed the development of several new products.

Dr. Cahill’s background includes over twenty years with Perkin-Elmer, where he held senior positions in applied research, product development, and technical marketing.  Prior to joining Perkin-Elmer he was on the faculty of Drexel University where he taught physical chemistry and established a research program in molecular spectroscopy. 

Trilogy Associates serves clients ranging in size from start-ups to Fortune-100 multinationals in industries including clinical diagnostics, laboratory and process instruments, surgical devices, pharmaceuticals, implanted devices, patient monitoring, biotechnology, electronics, specialty chemicals, medical informatics, and publishing. He has been elected to membership in Sigma Xi, Tau Beta Pi and Eta Kappa Nu honoraries and has published in 11 professional journals. He is a member of the MIT Enterprise Forum of Cambridge.

His career started with the Aerospace Physics Laboratory of GE's Missile and Space Division. He then joined Battelle Memorial Institute as an expert in computer-aided design, where he spent five years executing and marketing contract research programs for numerous government and industrial clients.

Mr. Kalinowski then joined the Corning corporate R&D organization. Over a period of 11 years, he was affiliated with Corning's medical and laboratory businesses in positions of increasing responsibilities for research, development, program management, line management, and eventually venture management for an emerging business in medical informatics for Ciba Corning Diagnostics (now Bayer Diagnostics).

Mr. Kalinowski then joined Ohmeda as Director of R&D for its noninvasive monitoring business in pulse oximetry. He was later recruited to join the management team of Betagen, a young biotechnology venture in DNA blot imaging, analysis, and preparation. He served as Vice President of Development with responsibility for existing products and the formulation of new business opportunities in the creation of tools for biotechnology research.

He took on an interim responsibility as Director of Business Development for Deknatel, a surgical devices firm, immediately following its leveraged buyout from Pfizer. At Deknatel (now part of Genzyme Biosurgery) he identified numerous new product opportunities for growth, brought ten initiatives through the business planning stage, and developed four external alliances for new business.

Dr. Lokshin is author of several technical papers and US Patents.     

Lokshin earned his B.S. in mathematics and M.S. in physics from the Leningrad Polytechnic Institute. He also holds a Ph.D. in Electrical Engineering from the University of Southern California.  

Terence Risby, Ph.D.  --  is Professor of Environmental Health Sciences at The Johns Hopkins University Bloomberg School of Public Health.  He also has joint appointments in the departments of  International Health and Pathology and in the Center for Human Nutrition.

Dr. Risby's research stresses the development of novel, highly sensitive analytical chemical approaches used as non-invasive biomarkers of tissue injury and disease, with primary application to the clinical setting. His laboratory has developed breath markers of biosynthesis of cholesterol, liver function and liver disease, and nutritional status. He has applied these techniques to human subjects of all ages, and in a variety of clinical situations, as, for example, in the premature infant and in patients undergoing transplantation surgery. More recently, he has initiated studies that are using his developed biomarkers of tissue injury to investigate the effects of exposure to environmental toxicants.

Dr. Risby's laboratory has a long-standing research interest in the inhalation of airborne particles with particular reference to emissions from mobile sources. The focus of these studies has been the development of theoretical models that can be used to predict the formation of airborne particulate matter and the subsequent release of adsorbed pollutant molecules in pulmonary surfactant and/or inside pulmonary phagocytic cells. These studies continue through investigations that are aimed at understanding the relationship between the physicochemistry of pollutant-particle complexes and the molecular biology of phagocytic and pulmonary epithelial cells.  

-------------------------------------    (TOP OF PAGE)    ---------------------------------------

Neil Rosenbaum, Ph.D.  --  began his professional career in 1988 at the Amoco Research Center in Naperville, IL, working as an analytical chemist.  His primary focus there was spectroscopy research, but also included services supporting other technical personnel throughout the corporation. This role made him familiar with a host of practical problems and served as a model for his style of crisp, practical results that are responsive to time and budgetary constraints.  While his specialty was FTIR, Dr. Rosenbaum had ample exposure to a multiplicity of methods, including Raman, UV/visible spectroscopy as well as hyphenated techniques such as GC-FTIR.  His use of chemometric methods, such as PLS, for extracting more useable information out of FTIR and UV/visible spectroscopy, resulted in large cost savings for Amoco when applied to its plant process control.   

Dr. Rosenbaum joined Top Source Technologies (currently known as Global Technovations, Inc. due to name change) in 1994.  There he developed and supported an instrument for lubricant analysis.  His work in instrumental and spectrometer design, operating software, and quantitative spectroscopic methods led to a lubricant analyzer that is currently being distributed worldwide.  This design incorporated both emission and infrared spectroscopy and led to two issued patents.  

Dr. Rosenbaum’s graduate research focused on laser spectroscopy of transient species (ions, radicals, etc.) generated in plasmas or trapped via quadrupole electric fields. His work was documented in 11 publications.   

He earned his BS in Chemistry from the University of Illinois and his Ph.D. in Physical Chemistry from the University of California, Berkeley under the direction of Professor Richard J. Saykally.

-------------------------------------    (TOP OF PAGE)    ---------------------------------------

-------------------------------------    (TOP OF PAGE)    ---------------------------------------